Keratinocyte growth factor Neurotrophic factor receptor Growth factor receptor inhibitor Tyrosine kinase inhibitor GDNF family of ligands Fibroblast growth factor Growth factor receptor Ramucirumab Ephrin Icrucumab Becaplermin Figitumumab Duligotuzumab Mirvetuximab soravtansine Rilotumumab Onartuzumab Ertumaxomab Neuregulin Ciliary neurotrophic factor receptor Robatumumab FGF16 FGF20 IGF-1 LR3 Ficlatuzumab Teprotumumab Emibetuzumab Imgatuzumab Cerebrolysin FGF15/19 Insulin-like growth factor-binding protein Flanvotumab Dalotuzumab Pertuzumab/trastuzumab/hyaluronidase Amivantamab Mecasermin rinfabate Faricimab Hemopoietic growth factor Pl…

latelet-derived growth factor FGF15 Fulranumab Futuximab Alacizumab pegol FGF22 Palifermin Matuzumab Ancestim Neurotrophin Trafermin Necitumumab Angiopoietin Nimotuzumab FGF11 Anti-VEGF Pertuzumab Des(1-3)IGF-1 Patritumab Cenegermin BNN-20 Adult neurogenesis Evinacumab R13 (drug) Norwogonin Neurotrophic factors Trastuzumab/hyaluronidase Seribantumab Tovetumab Dusigitumab Semaxanib Bevacizumab Trk receptor C

etuximab Eutropoflavin LM22A-4 Brolucizumab Cixutumumab Persephin Ganitumab GFRα Neurturin Zalutumumab Fasinumab Nesvacumab HIOC Motesanib Cediranib ANA-12 Dihexa Vascular endothelial growth factor Fruquintinib Trofinetide IGFBP7 RTK class III 7,8,3'-Trihydroxyflavone Glia maturation factor Grandinin Mecasermin Selpercatinib Nilotinib Asciminib Brigatinib Binimetinib Rociletinib Pralsetinib Olmutinib Tyrosine kinase Receptor activity-modifying protein Linsitinib Renalase Tepotinib Neratinib Trastuzumab emtansine Epigen Olaratumab R7 (drug) Panitumumab Ranibizumab Trastuzumab Trametinib Avapritinib Neu